Second-Generation BTK Inhibitors for CLL

[Jm954]

A short video (or transcript) from PATIENT POWER

"The approval of the first BTK inhibitor was a game changer for the treatment of CLL. In this video, Jacqueline Claudia Barrientos, MD, MS, of Northwell Health gives an overview of second-generation BTK inhibitors, their side effect profile, and how they differ from first-generation BTK inhibitors. Dr. Barrientos also discusses recently approved therapies, the status of those still in clinical trials, and the questions CLL patients should be asking their medical teams to improve outcomes."

Link here: patientpower.info/second-ge...

Jackie

[louie48]

Thanks Jackie. I Bookmarked the article.